Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims database.

Yuko Kaneko Hideto Kameda Kei IkedaKatsuhisa YamashitaRyoto Ozaki Yoshiya Tanaka

Published in: International journal of rheumatic diseases (2023)

The use of interleukin-6 inhibitors increased by 7.5% points in Japanese patients with ASD ~2 years after TCZ-IV approval, suggesting that an unmet medical need existed. This study suggests the potential GC-sparing effect of TCZ-IV in patients with ASD in clinical practice.

Keyphrases

autism spectrum disorder
clinical practice
healthcare
attention deficit hyperactivity disorder
rheumatoid arthritis
emergency department
risk assessment
mass spectrometry
minimally invasive
solid phase extraction